Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06079034 · ClinicalTrials.gov registry record
Impact of Cannulation Strategy on Neurologic Injury in Infants With Respiratory Failure
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 5,058
- Enrollment target
NCT06079034: Completed study, sponsored by University of Michigan.
NCT06079034 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 5,058 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06079034 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 5,058 participants
- Enrollment target
Study Summary
There has been increasing use of venoarterial (VA) extracorporeal membrane oxygenation (ECMO) for infants with respiratory failure, up to 92% of neonatal respiratory support in 2021. This study seeks to leverage the increased use of VA ECMO in this cohort to enrich an evaluation of the differences in rate of intracranial hemorrhage and ischemic stroke between venovenous (VV) and VA ECMO among infants with respiratory failure where clinicians may choose either strategy. This project is a retrospective review of data in the ELSO registry.
Primary Outcome
The outcome will be the composite occurrence of neurologic injury (ischemic stroke, intracranial hemorrhage, and brain death) that arises during critical illness supported by extracorporeal life support (ECLS) as reported to the Extracorporeal Life Support Organization (ELSO) registry, coded as a 0/1 variable (0 = no occurrence was reported during or after ECMO; 1 = one or more occurrence was reported).
Interventions
- PROCEDURE Venovenous ECMO
- PROCEDURE Venoarterial ECMO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,058 participants |
| Start Date | 2023-10-18 |
| Est. Completion | 2023-12-12 |
What the finished NCT06079034 record still lists
NCT06079034 is an observational study that tracks outcomes without assigning an intervention. Its 5,058 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Venovenous ECMO is the first listed.
NCT06079034 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06079034 about?
NCT06079034 is a clinical study titled "Impact of Cannulation Strategy on Neurologic Injury in Infants With Respiratory Failure". There has been increasing use of venoarterial (VA) extracorporeal membrane oxygenation (ECMO) for infants with respiratory failure, up to 92% of neonatal respiratory support in 2021. This study seeks to leverage the increased use of VA ECMO in this cohort to enrich an evaluation of the differences i...
What is the current status of trial NCT06079034?
This trial is currently completed. The enrollment target is 5,058 participants. The study started on 2023-10-18. Estimated completion is 2023-12-12.
What interventions are being tested in trial NCT06079034?
The interventions under investigation include: Venovenous ECMO (PROCEDURE), Venoarterial ECMO (PROCEDURE).
Who is sponsoring clinical trial NCT06079034?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07037459 · 5,056 participants · Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- NCT06292078 · 5,076 participants · NA
Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)
- NCT05018611 · 5,100 participants · NA
Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW
- NCT05701358 · 5,100 participants · NA
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI